88 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or as a result of the termination, death or disability of such employee, director, manager or consultant.
“Dollars,” “dollars” or use of the sign
8-K
hocjleq gqilx9q8bqod
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-99.1
2a4puybxe h3kkekax
27 Oct 23
Regulation FD Disclosure
4:19pm
8-K
EX-99.1
jre9pjje7nzcggxhifz9
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
0lnq5w69tne0zd8f4h
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
ujoerljrb8q myq
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
8-K
8g7kin q75ifek31si
20 Jul 23
Departure of Directors or Certain Officers
5:01pm
S-4
n07klap pi9f2o5r
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
c006hjb7c
16 Jun 23
Business combination disclosure
8:08am
425
e7eybx6zoqw6c4khzjw2
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
jgs0cwto w9x8q4
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am